Beta-2-Microglobulin is a blood plasma protein found in all nucleated cells. One of its functions is to regulate endocytosis of iron into intestinal cells. Loss of this function causes iron excess and hemochromatosis. In patients on long-term hemodialysis, it can aggregate into amyloid fibers that deposit in joint spaces, a disease known as dialysis-related amyloidosis. Levels of B2M in the serum can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumors and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy). In clinical diagnostics it is most widely used to evaluate the severity and prognosis of multiple myeloma, leukaemia, or lymphoma and to distinguish between kidney disorders and to detect kidney damage.
| Abbreviation | B2M, β2M |
| Synonyms | β2 Microglobulin |
| Molecular Weight | 12 kDa |
| Variant Name | Product Code | Purity | |
|---|---|---|---|
+ |
Beta-2-Microglobulin, standard grade | P122-2 | Standard |
+ |
Beta-2-Microglobulin, highly pure | P122-1 | Highly Pure |